Hildred Capital

Hildred Capital Partners, LLC, established in 2014, is a New York-based multi-family office and private equity firm. It invests in a broad range of securities, including equity and debt, across various geographies and sectors, both actively and passively. The firm has a particular interest in private equity, leveraging its principals' extensive management experience to help companies reach their full potential. Hildred Capital Management, LLC, a subsidiary, specializes in growth equity and lower middle-market investments, focusing on healthcare services, information technology, medical devices, consumer products, and pharmaceuticals. The firm typically invests between $20 million and $75 million in companies with a maximum revenue of $100 million and an enterprise value of $50 million to $250 million, primarily in North America.

Andrew Goldman

Co-Founder and Managing Partner

David F. Solomon

Co-Founder, Managing Partner

9 past transactions

Binx

Series F in 2024
Binx Health Limited is an in vitro diagnostics company based in Trowbridge, United Kingdom, founded in 2005. The company specializes in developing diagnostic instruments and disposable cartridge systems for decentralized laboratory and point-of-care settings. Its flagship product, the binx io platform, is the first FDA-cleared, CLIA-waived system for detecting chlamydia and gonorrhea in both males and females, delivering results comparable to central laboratory performance within approximately thirty minutes. Binx Health aims to enhance healthcare access by addressing traditional barriers and extending outreach through its point-of-care diagnostic solutions. The company also focuses on providing rapid polymerase chain reaction (PCR)-based results and a comprehensive digital program that includes evidence-based testing, counseling, treatment, and follow-up services. Binx Health has established a strategic partnership with Sherlock Biosciences, further strengthening its commitment to improving community health outcomes.

Hello Bello

Acquisition in 2023
Hello Bello is an online retailer based in Pacific Palisades, California, specializing in eco-friendly children's products. Founded in 2018, the company offers a diverse range of items made with plant-based ingredients and organic botanicals, including premium diapers, shampoo, body wash, baby wipes, bubble baths, diaper rash cream, sanitizer, and lotion. The brand aims to provide parents with high-quality, affordable alternatives for their children's necessities, positioning itself as a reliable choice in the market for those seeking natural and environmentally conscious baby care solutions.

AleraCare

Private Equity Round in 2023
AleraCare Holdings is a healthcare provider that specializes in home and community-based services, focusing on high-need and medically complex populations. The company offers specialty pharmacy and home infusion services, delivering specialty medications and treatments for various conditions, including oncology, rheumatoid arthritis, multiple sclerosis, and Crohn's disease. By concentrating on chronic illnesses, AleraCare aims to facilitate complex and efficient treatment for its patients in a convenient manner.

HealthCare.com

Series C in 2022
HealthCare.com is an online health insurance company that offers a data-driven shopping platform to assist American consumers in enrolling in individual health insurance and Medicare plans. Founded in 2014 and headquartered in New York City, the company utilizes artificial intelligence and machine learning to enhance user experiences, enabling customers to find, compare, and purchase insurance products that best meet their needs. HealthCare.com also markets proprietary health insurance and supplemental insurance products under the name Pivot Health. Its services include a comparison platform that provides expert advice, data, and personalized recommendations, empowering users to make informed decisions regarding their healthcare coverage. The company has been recognized as one of America's fastest-growing businesses, earning a spot on the Inc. 5000 list multiple times.

Binx

Series E in 2021
Binx Health Limited is an in vitro diagnostics company based in Trowbridge, United Kingdom, founded in 2005. The company specializes in developing diagnostic instruments and disposable cartridge systems for decentralized laboratory and point-of-care settings. Its flagship product, the binx io platform, is the first FDA-cleared, CLIA-waived system for detecting chlamydia and gonorrhea in both males and females, delivering results comparable to central laboratory performance within approximately thirty minutes. Binx Health aims to enhance healthcare access by addressing traditional barriers and extending outreach through its point-of-care diagnostic solutions. The company also focuses on providing rapid polymerase chain reaction (PCR)-based results and a comprehensive digital program that includes evidence-based testing, counseling, treatment, and follow-up services. Binx Health has established a strategic partnership with Sherlock Biosciences, further strengthening its commitment to improving community health outcomes.

DermCare Management

Private Equity Round in 2019
DermCare Management is a dermatology practice management company founded by experienced dermatology professionals. It focuses on partnering with dermatologists to enhance patient loyalty and practice growth by combining clinical expertise with management support. The company provides administrative assistance and resources, allowing dermatologists to concentrate on delivering high-quality care. DermCare Management aims to foster a team-oriented environment in healthcare, emphasizing collaboration and effective management to ensure the continued success of its partner practices. Through its services, DermCare Management addresses the unique challenges faced by dermatology practices, enabling them to thrive in a competitive landscape while maintaining a commitment to exceptional patient care.

Crown Laboratories

Private Equity Round in 2019
Crown Laboratories, Inc. is a specialty pharmaceutical company based in Johnson City, Tennessee, founded in 2000. The company focuses on producing both prescription and non-prescription drugs, as well as cosmetic products aimed at enhancing skin health. Its product portfolio includes a range of aesthetic solutions such as SkinPen and Skinfuse, beauty products like Body Blur and Beauty Blur, and therapeutic options including Blue Lizard and PanOxyl. Additionally, Crown Laboratories offers contract manufacturing services for various formulations including solid, liquid, and semi-liquid gels and creams. The company's commitment to dermatology drives its mission to improve the quality of life for consumers through effective skincare solutions.

Crown Laboratories

Private Equity Round in 2017
Crown Laboratories, Inc. is a specialty pharmaceutical company based in Johnson City, Tennessee, founded in 2000. The company focuses on producing both prescription and non-prescription drugs, as well as cosmetic products aimed at enhancing skin health. Its product portfolio includes a range of aesthetic solutions such as SkinPen and Skinfuse, beauty products like Body Blur and Beauty Blur, and therapeutic options including Blue Lizard and PanOxyl. Additionally, Crown Laboratories offers contract manufacturing services for various formulations including solid, liquid, and semi-liquid gels and creams. The company's commitment to dermatology drives its mission to improve the quality of life for consumers through effective skincare solutions.

Pharmaceutics International

Venture Round in 2016
Pharmaceutics International, Inc. is a contract development and manufacturing company that specializes in dosage form development and cGMP manufacturing services for the biotech and specialty pharmaceutical sectors both in the United States and internationally. Founded in 1994 and based in Hunt Valley, Maryland, the company produces a diverse array of dosage forms, including conventional and controlled-release tablets, soft gels, and sterile injectable products, among others. In addition to manufacturing, Pharmaceutics International offers a comprehensive suite of services such as pre-formulation, formulation, clinical trial materials manufacturing, and clinical packaging and labeling. The company is dedicated to enhancing drug quality through innovative technologies and scientific expertise, while also providing regulatory and project management support to its clients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.